AAAAAA

   
Results: 1-12 |
Results: 12
Cytokines as adjuvants for the induction of mucosal immunity
Authors: Boyaka, PN McGhee, JR
Citation: Pn. Boyaka et Jr. Mcghee, Cytokines as adjuvants for the induction of mucosal immunity, ADV DRUG DE, 51(1-3), 2001, pp. 71-79
Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity
Authors: Boyaka, PN Marinaro, M Jackson, RJ van Ginkel, FW Cormet-Boyaka, E Kirk, KL Kensil, CR McGhee, JR
Citation: Pn. Boyaka et al., Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity, J IMMUNOL, 166(4), 2001, pp. 2283-2290
RANTES potentiates antigen-specific mucosal immune responses
Authors: Lillard, JW Boyaka, PN Taub, DD McGhee, JR
Citation: Jw. Lillard et al., RANTES potentiates antigen-specific mucosal immune responses, J IMMUNOL, 166(1), 2001, pp. 162-169
A revisit of mucosal IgA immunity and oral tolerance
Authors: Fujihashi, K Kato, H van Ginkel, FW Koga, T Boyaka, PN Jackson, RJ Kato, R Hagiwara, Y Etani, Y Goma, I Fujihashi, K Kiyono, H McGhee, JR
Citation: K. Fujihashi et al., A revisit of mucosal IgA immunity and oral tolerance, ACT ODON SC, 59(5), 2001, pp. 301-308
Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl- currents
Authors: Naren, AP Di, A Cormet-Boyaka, E Boyaka, PN McGhee, JR Zhou, WH Akagawa, K Fujiwara, T Thome, U Engelhardt, JF Nelson, DJ Kirk, KL
Citation: Ap. Naren et al., Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl- currents, J CLIN INV, 105(3), 2000, pp. 377-386
Human nasopharyngeal-associated lymphoreticular tissues - Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils
Authors: Boyaka, PN Wright, PF Marinaro, M Kiyono, H Johnson, JE Gonzales, RA Ikizler, MR Werkhaven, JA Jackson, RJ Fujihashi, K Di Fabio, S Staats, HF McGhee, JR
Citation: Pn. Boyaka et al., Human nasopharyngeal-associated lymphoreticular tissues - Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils, AM J PATH, 157(6), 2000, pp. 2023-2035
Interleukin 12 and innate molecules for enhanced mucosal immunity
Authors: Boyaka, PN Lillard, JW McGhee, J
Citation: Pn. Boyaka et al., Interleukin 12 and innate molecules for enhanced mucosal immunity, IMMUNOL RES, 20(3), 1999, pp. 207-217
Mechanisms for induction of acquired host immunity by neutrophil peptide defensins
Authors: Lillard, JW Boyaka, PN Chertov, O Oppenheim, JJ McGhee, JR
Citation: Jw. Lillard et al., Mechanisms for induction of acquired host immunity by neutrophil peptide defensins, P NAS US, 96(2), 1999, pp. 651-656
Lymphotactin acts as an innate mucosal adjuvant
Authors: Lillard, JW Boyaka, PN Hedrick, JA Zlotnik, A McGhee, JR
Citation: Jw. Lillard et al., Lymphotactin acts as an innate mucosal adjuvant, J IMMUNOL, 162(4), 1999, pp. 1959-1965
Use of intranasal IL-12 to target predominantly Th1 responses to nasal andTh2 responses to oral vaccines given with cholera toxin
Authors: Marinaro, M Boyaka, PN Jackson, RJ Finkelman, FD Kiyono, H Jirillo, E McGhee, JR
Citation: M. Marinaro et al., Use of intranasal IL-12 to target predominantly Th1 responses to nasal andTh2 responses to oral vaccines given with cholera toxin, J IMMUNOL, 162(1), 1999, pp. 114-121
IL-12 is an effective adjuvant for induction of mucosal immunity
Authors: Boyaka, PN Marinaro, M Jackson, RJ Menon, S Kiyono, H Jirillo, E McGhee, JR
Citation: Pn. Boyaka et al., IL-12 is an effective adjuvant for induction of mucosal immunity, J IMMUNOL, 162(1), 1999, pp. 122-128
Strategies for mucosal vaccine development
Authors: Boyaka, PN Marinaro, M Vancott, JL Takahashi, I Fujihashi, K Yamamoto, M van Ginkel, FW Jackson, RJ Kiyono, H McGhee, JR
Citation: Pn. Boyaka et al., Strategies for mucosal vaccine development, AM J TROP M, 60(4), 1999, pp. 35-45
Risultati: 1-12 |